CN114556101B - 癌的检查方法 - Google Patents

癌的检查方法

Info

Publication number
CN114556101B
CN114556101B CN202080071169.XA CN202080071169A CN114556101B CN 114556101 B CN114556101 B CN 114556101B CN 202080071169 A CN202080071169 A CN 202080071169A CN 114556101 B CN114556101 B CN 114556101B
Authority
CN
China
Prior art keywords
molecule
cancer
binding
bc2lcn
gal3bp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080071169.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN114556101A (zh
Inventor
馆野浩章
小田竜也
下村治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology
University of Tsukuba
Original Assignee
National Institute of Advanced Industrial Science and Technology
University of Tsukuba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Advanced Industrial Science and Technology, University of Tsukuba filed Critical National Institute of Advanced Industrial Science and Technology
Publication of CN114556101A publication Critical patent/CN114556101A/zh
Application granted granted Critical
Publication of CN114556101B publication Critical patent/CN114556101B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4724—Lectins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8125—Alpha-1-antitrypsin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
CN202080071169.XA 2019-10-11 2020-10-09 癌的检查方法 Active CN114556101B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-187197 2019-10-11
JP2019187197 2019-10-11
PCT/JP2020/038300 WO2021070934A1 (ja) 2019-10-11 2020-10-09 がんの検査方法

Publications (2)

Publication Number Publication Date
CN114556101A CN114556101A (zh) 2022-05-27
CN114556101B true CN114556101B (zh) 2025-09-26

Family

ID=75438180

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080071169.XA Active CN114556101B (zh) 2019-10-11 2020-10-09 癌的检查方法

Country Status (6)

Country Link
US (1) US12618842B2 (cg-RX-API-DMAC7.html)
EP (1) EP4043881A4 (cg-RX-API-DMAC7.html)
JP (1) JP7656829B2 (cg-RX-API-DMAC7.html)
KR (1) KR102896955B1 (cg-RX-API-DMAC7.html)
CN (1) CN114556101B (cg-RX-API-DMAC7.html)
WO (1) WO2021070934A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022182394A (ja) * 2021-05-28 2022-12-08 独立行政法人国立病院機構 抗原固相化デバイス
WO2025187809A1 (ja) * 2024-03-08 2025-09-12 富士フイルム株式会社 検出対象物質を免疫学的に検出する方法、非特異反応を抑制する方法、フコース含有組成物、および試薬キット

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017061449A1 (ja) * 2015-10-05 2017-04-13 国立研究開発法人産業技術総合研究所 がん細胞の検出方法、がん細胞内に物質を導入するための試薬、及びがん治療用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
JP5977743B2 (ja) 2011-06-15 2016-08-24 三洋化成工業株式会社 磁性シリカ粒子を用いた測定方法及び該測定方法用試薬
WO2013172105A1 (ja) * 2012-05-18 2013-11-21 日東紡績株式会社 膵臓癌を検出するためのマーカー
WO2014126146A1 (ja) 2013-02-14 2014-08-21 独立行政法人産業技術総合研究所 未分化細胞除去方法
US11078254B2 (en) 2017-04-11 2021-08-03 National Institute Of Advanced Industrial Science And Technology Method for immobilizing lectin
JP7386647B2 (ja) 2018-08-13 2023-11-27 東ソー株式会社 糖鎖への親和性が向上したフコース結合性タンパク質、およびその製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017061449A1 (ja) * 2015-10-05 2017-04-13 国立研究開発法人産業技術総合研究所 がん細胞の検出方法、がん細胞内に物質を導入するための試薬、及びがん治療用組成物

Also Published As

Publication number Publication date
KR20220079855A (ko) 2022-06-14
JP7656829B2 (ja) 2025-04-04
EP4043881A1 (en) 2022-08-17
WO2021070934A1 (ja) 2021-04-15
EP4043881A4 (en) 2022-11-23
US12618842B2 (en) 2026-05-05
KR102896955B1 (ko) 2025-12-05
US20220236275A1 (en) 2022-07-28
CN114556101A (zh) 2022-05-27
JPWO2021070934A1 (cg-RX-API-DMAC7.html) 2021-04-15

Similar Documents

Publication Publication Date Title
JP5787389B2 (ja) 肝内胆管がんの検出、判別方法
CN112345755B (zh) 乳腺癌的生物标志物及其应用
JP7490007B2 (ja) レクチンベースのがんの診断
Park et al. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach
WO2022083673A1 (zh) 食管癌的生物标志物及其应用
CN104395758A (zh) 用于检测胰腺癌的标志物
WO2016195051A1 (ja) 膵がんを診断するための血漿バイオマーカーパネル
WO2022083603A1 (zh) 半胱氨酸蛋白酶抑制剂与Cathepsin复合物作为肿瘤诊断标志物的应用
US12618842B2 (en) Cancer test method
CN115877006B (zh) 卵巢癌相关的生物标志物及其应用
ES2974307T3 (es) PERM como marcador de cáncer de endometrio
CN120334544B (zh) 鼻咽癌抗体标志物及其应用
KR101144324B1 (ko) 대장암 예후진단용 단백질 마커 디펜신?5와 rod1단백질의 조합 및 이들 각각에 대한 항체를 포함하는 대장암 예후진단키트
CA3255282A1 (en) METHODS AND SYSTEMS FOR RISK STRATIFICATION AND BLADDER CANCER MANAGEMENT
CN116539885A (zh) 用于乳腺癌早期检测的肿瘤自身抗原/抗体组合及应用
CN115372616A (zh) 胃癌相关的生物标志物及其应用
US20260086095A1 (en) Methods for detection of prostate cancer, related biomarkers and kits for determining the biomarkers
KR102325742B1 (ko) 암의 진단용 조성물
WO2022186318A1 (ja) がん検出方法、がん検査方法、及びこれらに用いるキット
JP2011107064A (ja) クラスリン重鎖に対する自己抗体の免疫測定方法、それに用いるキット、及びそれを用いた癌判定方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant